Adaptive Immunity

On this page

Adaptive Immunity: Overview - The Smart Defenders

  • Specificity: Precisely targets unique pathogen antigens.
  • Memory: Enables faster, stronger response upon re-exposure (anamnestic response). 📌 Secondary response is Stronger & Swifter.
  • Diversity: Generates a vast repertoire of antigen receptors.
  • Self/Non-self Discrimination: Crucial for preventing autoimmunity.
  • Key players: T lymphocytes (cell-mediated immunity) & B lymphocytes (humoral immunity).

⭐ Clonal selection theory, proposed by Burnet, forms the basis of adaptive immunity, explaining lymphocyte specificity and memory.

Cells: T & B Lymphocytes - The Immune Troops

  • T-Lymphocytes (T-cells): Cell-mediated immunity.
    • Origin: Bone Marrow. Maturation: Thymus (📌 T for Thymus).
    • Markers: CD3 (pan T-cell), CD4 (Helper), CD8 (Cytotoxic).
    • CD4+ T-cells (Helper): Orchestrate response; activate B-cells, macrophages.
    • CD8+ T-cells (Cytotoxic): Lyse infected/tumor cells.
  • B-Lymphocytes (B-cells): Humoral immunity.
    • Origin & Maturation: Bone Marrow (📌 B for Bone Marrow).
    • Function: Differentiate to plasma cells → secrete antibodies.
    • Markers: CD19, CD20.

⭐ Positive and negative selection in the thymus are crucial for T cell development and self-tolerance.

Loading diagram…

Antigen Presentation: MHC - The ID Checkpoint

  • MHC (HLA in humans): Cell surface glycoproteins; present processed antigen peptides to T-cells.
  • Key for T-cell activation and self/non-self discrimination.
FeatureMHC Class IMHC Class II
CellsAll nucleatedAPCs (macrophages, DCs, B-cells)
AntigenEndogenous (viral, tumor)Exogenous (e.g., bacterial)
BindsCD8+ T-cellsCD4+ T-cells
PathwayCytosolic; TAP to EREndocytic; MIIC
📌 MnemonicRule of 8: 1 x 8 = 8Rule of 8: 2 x 4 = 8
Loading diagram…

⭐ MHC gene polymorphism (HLA in humans) is responsible for transplant rejection and susceptibility to autoimmune diseases.

Humoral Immunity: Antibodies - The Armada Unleashed

  • B-cells, activated by antigen (often with T-cell help), differentiate into plasma cells (antibody factories) and memory B-cells.
  • Antibodies (Immunoglobulins - Ig): Y-shaped proteins.
    • Fab region: Antigen-binding.
    • Fc region: Effector functions (e.g., opsonization, complement activation).
  • Key Functions: Neutralization, Opsonization, Complement activation (classical pathway), Antibody-Dependent Cell-mediated Cytotoxicity (ADCC).
  • 📌 Antibody Isotypes (Mnemonic: GAMED):
    IsotypeStructureKey Feature(s)
    IgGMonomerMain serum Ab, crosses placenta, opsonization
    IgADimer (secretory)Mucosal immunity (tears, saliva, gut)
    IgMPentamerFirst responder (primary), potent complement fixer
    IgEMonomerAllergic reactions, parasite defense
    IgDMonomerB-cell surface receptor, role unclear

⭐ IgM is the first antibody produced during a primary immune response and exists as a pentamer, making it highly effective at activating complement.

Cell-Mediated Immunity: T Cells - The Direct Attackers

  • Primary defense: Intracellular pathogens (viruses, specific bacteria) & tumor cells.
  • Key Players:
    • Cytotoxic T Lymphocytes (CTLs/CD8+): Directly kill target cells. Recognize antigen + MHC-I.
      • Mechanisms: Perforin, Granzymes, Fas-FasL.
    • Helper T Lymphocytes (Th/CD4+): Orchestrate immunity. Recognize antigen + MHC-II.
      • Subsets: Th1 (CMI), Th2 (Humoral), Th17 (Inflammation).
  • Activation: TCR binds Ag-MHC + co-stimulation (e.g., CD28-B7).

⭐ IFN-γ, produced by Th1 cells and NK cells, is crucial for macrophage activation and cell-mediated immunity against intracellular pathogens.

Loading diagram…

High‑Yield Points - ⚡ Biggest Takeaways

  • T cells mature in the thymus; B cells in bone marrow.
  • MHC I (all nucleated cells) presents endogenous antigens to CD8+ T cells.
  • MHC II (APCs) presents exogenous antigens to CD4+ T cells.
  • T-cell activation requires two signals: TCR-MHC/peptide and B7-CD28 co-stimulation.
  • B cells undergo isotype switching and somatic hypermutation for antibody diversity.
  • Memory B and T cells mediate rapid and robust secondary immune responses.
  • Regulatory T cells (Tregs), often CD4+ CD25+ FOXP3+, maintain peripheral tolerance.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Adaptive Immunity

  1. 1. The technique shown in the picture is used for:

    • A. Process of genetic engineering
    • B. Preparing cell lines for viral culture
    • C. Synthesis of monoclonal antibodies
    • D. Synthesis of vaccine preparations
    Show answer

    Answer: C. Synthesis of monoclonal antibodies

    Synthesis of monoclonal antibodies - Immunized mouse spleen cells are fused with myeloma cells to form hybridomas capable of continuous growth and antibody secretion. - HAT medium selects surviving hybridomas; screening identifies those producing the desired antibody, and single-cell cloning establishes monoclonal antibody-producing lines. Process of genetic engineering - Genetic engineering involves deliberate manipulation of DNA, such as gene cloning, insertion of foreign DNA, or gene editing, rather than cellular fusion alone. - Although molecular techniques may support antibody production, the defining procedure shown is hybridoma formation, not conventional genetic engineering. Preparing cell lines for viral culture - Viral culture requires growing susceptible cells and inoculating them with a virus to permit replication and study. - The depicted fusion of immunized spleen cells with myeloma cells creates hybridomas, which is unrelated to preparing routine cell lines for viral propagation. Synthesis of vaccine preparations - Vaccines contain antigens such as attenuated or inactivated microbes, or recombinant proteins, designed to stimulate active immune responses. - The technique produces antibodies from hybridoma cells rather than vaccine antigens, so it is not primarily a method of vaccine synthesis.

  2. 2. What is the chromosomal translocation associated with Acute Myeloid Leukemia M3?

    • A. t(9;11)(p21.3;q23.3)
    • B. t(8;21)(q22;q22.1)
    • C. t(9;22)(q34.12;q11.23)
    • D. t(15;17)(q24.1;q21.2)
    Show answer

    Answer: D. t(15;17)(q24.1;q21.2)

    t(15;17)(q24.1;q21.2) - t(15;17)(q24.1;q21.2) is characteristic of acute promyelocytic leukemia (AML M3) and produces the PML-RARA fusion gene. - The resulting promyelocytic leukemia commonly shows heavily granulated promyelocytes and clinically important coagulopathy. t(9;11)(p21.3;q23.3) - t(9;11)(p21.3;q23.3) is primarily associated with AML M5, not acute promyelocytic leukemia (AML M3). - Its KMT2A-MLLT3 fusion and association with monocytic differentiation distinguish it from the PML-RARA rearrangement of AML M3. t(8;21)(q22;q22.1) - t(8;21)(q22;q22.1) is associated with AML M2 and produces the RUNX1-RUNX1T1 fusion gene. - Although it is a characteristic AML translocation, it does not account for the promyelocytic differentiation of AML M3. t(9;22)(q34.12;q11.23) - t(9;22)(q34.12;q11.23) produces the BCR-ABL1 fusion gene, which characteristically occurs in chronic myeloid leukemia (CML) rather than defining AML M3. - It is not linked to the PML-RARA fusion or the characteristic clinical features of acute promyelocytic leukemia.

  3. 3. Which type of lymphocyte is characterized by the following markers: CD3-, CD16+, CD56+, and responds to IL-12?

    • A. B-lineage lymphocytes
    • B. Natural killer cells
    • C. T helper 1 lymphocytes
    • D. Cytotoxic T lymphocytes
    Show answer

    Answer: B. Natural killer cells

    Natural killer cells - Natural killer (NK) cells are CD3-negative and express CD16 and CD56, matching the marker profile in the question. - They respond to IL-12, which enhances cytotoxicity and interferon-gamma production during innate responses against viruses and tumour cells. B-lineage lymphocytes - B-lineage lymphocytes lack CD3, but they characteristically express CD19, CD20, and surface immunoglobulin rather than CD16 and CD56. - Their primary function is antibody production, not the innate cytotoxicity associated with NK cells; they also respond to distinct cytokine profiles. T helper 1 lymphocytes - T helper 1 lymphocytes are a CD4-positive T-cell subset and therefore express CD3, unlike the CD3-negative cells described here. - Their main role is coordinating cell-mediated immunity through IFN-γ and IL-2, not CD16/CD56-associated direct cytotoxicity. Cytotoxic T lymphocytes - Cytotoxic T lymphocytes express CD3 and usually CD8, enabling T-cell receptor recognition of antigen presented on MHC class I. - They typically do not express CD16 or CD56, so their phenotype and activation mechanism do not fit the described lymphocyte.

  4. 4. A four-year-old boy presented with a two-month history of abdominal pain and fever, a ten-day history of maculopapular rash, and three days of dry cough, dyspnea, and wheezing. On examination, the liver and spleen were enlarged, measuring 4 cm and 3 cm below the costal margin, respectively. His hemoglobin was 10.0 g/dL, platelet count was 3.7 x 10^5/µL, and total leukocyte count was 70 x 10^3/µL, with 80% eosinophils. Bone marrow examination revealed a cellular marrow with 45% blasts, 34% eosinophils, and eosinophilic precursors. The blasts stained negative for myeloperoxidase and non-specific esterase and were positive for CD19, CD10, CD22, and CD20. Which statement about this disease is NOT true?

    • A. Frequent inv(16) in both populations
    • B. Reactive, non-neoplastic eosinophils
    • C. t(5;14) rearrangement in lymphoblasts
    • D. Eosinophil normalization with chemotherapy
    Show answer

    Answer: A. Frequent inv(16) in both populations

    Frequent inv(16) in both populations - Inv(16) is characteristic of AML with myelomonocytic differentiation and abnormal eosinophils, not typically B-ALL with hypereosinophilia. - In this case, the B-cell immunophenotype and reactive eosinophilia do not support inv(16) as a usual finding in the blasts and eosinophils. Reactive, non-neoplastic eosinophils - The eosinophils are generally reactive, produced in response to cytokines released by the leukemic lymphoblasts rather than arising from the malignant clone. - This distinguishes B-ALL with eosinophilia from AML with inv(16), in which the eosinophils are part of the neoplastic clone. t(5;14) rearrangement in lymphoblasts - The t(5;14)(q31;q32) rearrangement is associated with B-ALL and hypereosinophilia, making this statement true. - It places the IL-3 gene under immunoglobulin heavy-chain regulatory influence, increasing IL-3 production and promoting eosinophilia. Eosinophil normalization with chemotherapy - Because the eosinophilia is reactive, it may resolve when successful chemotherapy eliminates the leukemic blasts and blast-derived IL-3 production falls. - Normalization reflects suppression of the blast-driven cytokine stimulus, but treatment response alone does not establish whether eosinophils are reactive or clonal.

  5. 5. Which feature is NOT characteristic of the classical secondary antibody response?

    • A. Markedly shortened lag period
    • B. Transient initial antibody decline
    • C. Strong T-dependent immune memory
    • D. Absent response to rechallenge
    Show answer

    Answer: D. Absent response to rechallenge

    Absent response to rechallenge is the exception because re-exposure to the same antigen ordinarily produces a secondary antibody response. Transient initial antibody decline can occur when pre-existing antibodies bind the challenge antigen, producing a negative phase. Strong T-dependent immune memory is characteristic of classical secondary responses to protein antigens. Markedly shortened lag period reflects the rapid activation of antigen-experienced cells.

  6. 6. Which antibody preparation cannot form a precipitating lattice with a soluble multivalent antigen at equivalence?

    • A. Monovalent Fab fragments
    • B. Intact bivalent IgG
    • C. Pentameric IgM
    • D. Divalent F(ab′)₂ fragments
    Show answer

    Answer: A. Monovalent Fab fragments

    Monovalent Fab fragments are correct because each fragment retains only one antigen-binding site and cannot cross-link antigens to support an extended antigen–antibody lattice. Intact bivalent IgG can bridge suitable multivalent antigens and therefore does not inherently prevent precipitation. Pentameric IgM can support lattice formation with suitable multivalent antigens at equivalence. Divalent F(ab′)₂ fragments retain two antigen-binding sites and can cross-link suitable multivalent antigens.

  7. 7. A 20-year-old man has recurrent disseminated Neisseria gonorrhoeae infections over 2 years. Which investigation is most appropriate to evaluate the underlying immunodeficiency?

    • A. Nitroblue tetrazolium test
    • B. C5-C9 complement assay
    • C. Quantitative immunoglobulin levels
    • D. C1 esterase inhibitor assay
    Show answer

    Answer: B. C5-C9 complement assay

    C5-C9 complement assay - Recurrent Neisseria infections strongly suggest deficiency of terminal complement components C5–C9, which assemble the membrane attack complex. - The membrane attack complex lyses Neisseria; therefore, a terminal complement assay is the most appropriate investigation for this underlying immunodeficiency. C1 esterase inhibitor assay - C1 esterase inhibitor testing evaluates hereditary angioedema, which causes recurrent episodes of swelling from dysregulated complement and kinin pathways. - It does not assess the bactericidal defect associated with recurrent Neisseria infections, which points instead toward terminal complement deficiency. Quantitative immunoglobulin levels - Quantitative immunoglobulin levels assess humoral immunity and are useful for antibody deficiencies such as common variable immunodeficiency. - These deficiencies more typically cause recurrent sinopulmonary infections with encapsulated bacteria, rather than the characteristic recurrent Neisseria pattern. Nitroblue tetrazolium test - The nitroblue tetrazolium test, or dihydrorhodamine assay, evaluates phagocyte NADPH oxidase function in chronic granulomatous disease. - Chronic granulomatous disease causes deep infections and abscesses with catalase-positive organisms, not the recurrent Neisseria infections suggesting a complement defect.

  8. 8. Which of the following is the principal cellular source of IL-2 after antigen stimulation?

    • A. Th cells
    • B. Neutrophils
    • C. NK cells
    • D. Macrophages
    Show answer

    Answer: A. Th cells

    Th cells - Activated helper T-cells (CD4+ T-cells) are the primary source of IL-2 after antigen presentation and T-cell activation. - IL-2 functions as a T-cell growth factor, promoting clonal expansion of antigen-specific T-cells and amplifying the immune response. Macrophages - Macrophages primarily secrete TNF-α, IL-1, IL-6, and IL-12 during inflammation and antigen presentation, rather than IL-2. - Although macrophages regulate immune responses, IL-2 secretion is characteristically associated with activated T-cells, making this option incorrect. Neutrophils - Neutrophils are phagocytic cells involved mainly in acute inflammation and bacterial killing, not in significant IL-2 secretion. - They primarily release chemokines and pro-inflammatory mediators, including IL-8 and IL-1β, so they are not the best answer. NK cells NK cells are important responders to IL-2 rather than its principal source. They characteristically secrete IFN-γ and TNF-α, so Helper T-cells remains the best answer.

  9. 9. Constitutive MHC class II expression for presenting exogenous peptides to peripheral CD4+ T cells is characteristic of:

    • A. Resting T lymphocytes
    • B. B lymphocytes
    • C. Platelets
    • D. Erythrocytes
    Show answer

    Answer: B. B lymphocytes

    B lymphocytes constitutively express MHC class II and present processed antigen to CD4+ T cells. Platelets express MHC class I but not normally MHC class II. Erythrocytes lack MHC molecules. Resting T lymphocytes express MHC class I but do not constitutively express MHC class II.

  10. 10. Which erythrocyte inclusion is indicated by the arrow?

    • A. Howell–Jolly bodies
    • B. Pappenheimer bodies
    • C. Cabot rings
    • D. Heinz bodies
    Show answer

    Answer: C. Cabot rings

    Cabot rings are thin purple ring-shaped or figure-of-eight erythrocyte inclusions, matching the arrowed structure. Howell–Jolly bodies are discrete round DNA remnants, which can also occur in megaloblastic anemia but do not form this ring. Pappenheimer bodies are clustered iron-containing granules rather than a continuous ring. Heinz bodies are precipitated hemoglobin inclusions best demonstrated with supravital staining rather than this thin ring morphology.

Flashcards: Adaptive Immunity

  1. 1. Is graft rejection humoral or cell mediated?

    Show answer

    Both

  2. 2. Vascular rejection in an organ graft is a Type hypersensitivity reaction.

    Show answer

    II

  3. 3. Acute hemolytic transfusion reaction (AHTR) is Ig mediated and caused by ABO incompatibility

    Show answer

    M

  4. 4. is a IHC marker seen with Breast carcinoma, urothelial carcinoma, salivary duct carcinoma and choriocarcinoma

    Show answer

    GATA3

  5. 5. The _____ Coombs test adds _____ and _____ to the patient's _____

    Show answer

    indirect · donor blood · anti-Ig antibody (Coombs reagent) · serum

  6. 6. Which blood type does not have any group antigens on RBC surfaces?

    Show answer

    Type O

  7. 7. LE cell is a phagocytic _____ or _____ that has engulfed the denatured nucleus of an injured cell

    Show answer

    neutrophil · macrophage

  8. 8. --- Do with heme ---\nType II Hypersensitivity Disorders - Cytotoxic:\nTransfusion Reaction\n- Antibody against _____\n- IgM isohemagglutinins formed naturally in response to bacterial flora cause opsonization and complement activation\n- Leads to hemolysis\nHemolytic Disease of the Newborn (Erythroblastosis fetalis)\nAntibody = _____\n- Formed in _____ mother carrying _____ child\n- First pregnancy _____ (doesn't have to be viable pregnancy)\n- Antibody crosses placenta and injures subsequent fetuses\n- Prevent with _____ (anti-Rh, binds fetal red cells and prevents mothers immune system from reacting)\nABO blood typing and screening for other preformed Abs; always done in case of transplants.\nUniversal donor: type _____\nUniversal recipient: type _____\n(Ex) Type A can donate to _____ and _____. Type A can receive donations from _____ and _____.\n- Anti-B antibodies prevent donation from type B and type AB.\nHLA Typing - Microcytotoxicity test\nTests for MHC _____\nTest hundreds of different haplotypes to find a potential match.\nCells recognized by antibody will be attacked by complement and thus become leaky and take up dye.\nHLA Typing - Mixed lymphocyte reaction\nTests for MHC class _____\nTake donor cells and irradiate them (prevent proliferation). Irradiated donor cells are mixed with recipient cells to see if proliferation occurs.\nHigher radioactivity (thymidine) signifies _____ compatibility.

    Show answer

    ABO blood glycoproteins · Anti-RhD+ IgG · Rh- · Rh+ · sensitizes · RhoGAM · O · AB · type A · type AB · type A · type O · class I (HLA-A, HLA-B) · II (HLA-DR) · lower

  9. 9. _____ cells are _____ cells characterized by the accumulation of multiple _____

    Show answer

    Mott · plasma · Russell bodies

  10. 10. _____ is caused by a defect in the _____ gene

    Show answer

    X-linked (Bruton) agammaglobulinemia · BTK

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF